MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has announced that Dr. Shankar Musunuri, the company’s Chairman, CEO, and Co-Founder, will present at NobleCon20, Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference. The event will take place on December 3-4, 2024, at the Executive Education Complex at Florida Atlantic University in Boca Raton, Florida.
Dr. Musunuri’s presentation is scheduled for Tuesday, December 3, 2024, at 1:30 p.m. ET in Presentation Room 3. He will highlight Ocugen’s clinical programs and share insights with attendees unfamiliar with the company’s goals and achievements.
“Every year, NobleCon showcases emerging growth companies from a variety of industries to a relevant investor audience,” said Dr. Musunuri. “I look forward to sharing an update on our clinical programs for attendees who may not yet be familiar with the Ocugen story.”
Beyond the scheduled presentation, Ocugen’s executive team will conduct one-on-one meetings with investors to outline the company’s strategy, particularly its work in modifier gene therapy.
A high-definition video webcast of Dr. Musunuri’s presentation will be accessible the day after the event. It will be available on the Events section of Ocugen’s website, Noble Capital Markets’ Conference website, and Channelchek, an investor portal by Noble. The webcast will remain available for 90 days for those unable to attend the presentation in person.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.